🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07576946
Active, not recruiting Observational

The SATURİSTA Device

NCT07576946 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-03-15
Last updated
2026-05-08

Condition(s) studied

Oxygen Therapy

Study summary

This study aims to evaluate the functional performance and feasibility of the Saturista system, a novel device designed for automated oxygen flow regulation based on continuous monitoring of oxygen saturation (SpO₂). The system integrates real-time physiological monitoring, wireless data transmission, and centralized visualization to support timely detection of oxygen desaturation and clinical decision-making.

A pilot feasibility study will be conducted in healthy volunteers using a scenario-based protocol, including baseline monitoring, controlled desaturation, probe disconnection, and signal recovery. The primary objective is to assess the system's ability to generate alarms in response to changes in SpO₂ and to display data in real time. Secondary objectives include evaluation of response time, signal management, and overall system stability.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy adult volunteers aged 18 years or older * Resting oxygen saturation (SpO₂) within the normal range at baseline * Ability to understand the study procedures and provide written informed consent * Willingness to participate in all planned testing scenarios Exclusion Criteria: * History of chronic respiratory disease, including asthma, chronic obstructive pulmonary disease, or interstitial lung disease * Known cardiovascular disease or any condition that may affect oxygen saturation or hemodynamic stability * Current respiratory symptoms, acute infection, or fever at the time of participation * Anemia, peripheral circulatory disorders, or any condition that may interfere with pulse oximetry measurements * Skin lesions, deformity, or injury at the intended probe placement site * Pregnancy * History of syncope, intolerance to short-duration breath-holding, or any condition that may increase risk during testing * Inability or unwillingness to comply with study procedures

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istinye University Istanbul Turkey (Türkiye)

More Koç University trials in Turkey

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07576946 on ClinicalTrials.gov ↗ ← All trials in Turkey